NT2 , DSMB only publicly unblinding study if they need to stop it for whatever reason..

Now with interim results , I never had personal experience , but good possibility that here also is the same...
FDA will notify them only if they decide to stop , I am not 100% sure here , but that will be my opinion.

But after interim I am really hopeful that study will be stopped...